The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
about
Next-generation sequencing in thyroid cancerQualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer.The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genesBethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis.Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making.Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis.Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.Invasive follicular variant of papillary thyroid cancer harboring the NRAS mutation Q61K and presenting with bone metastasis-A case report.Significant associations between driver gene mutations and DNA methylation alterations across many cancer types.Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.Paediatric follicular thyroid carcinoma - indolent cancer with low prevalence of RAS mutations and absence of PAX8-PPARG fusion in a Japanese population.Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma.The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.
P2860
Q28079384-4F928C22-2AFF-4DF0-A697-02E887967437Q33834221-39BF0C14-E467-4592-A243-1EDDAF5A62FBQ35906046-1EA79345-13BE-4F72-8922-AE35BEF5B06CQ35906347-087EF3A2-3CF8-4A2D-9947-5104A8C90FD7Q36582693-636804A2-CDE4-4823-B06C-44D004ED52BFQ37616582-3E0B0A02-FD3A-4B8D-978E-660643174A09Q38614394-D616F560-0170-4319-BAC7-6C01E8A1E775Q38894925-EAEF3D40-7252-4870-ABB4-B9F2738AA1A3Q39480385-3D6EE8F5-5F50-4138-A779-35D4B7422005Q41288884-674E8A22-BCA2-463B-947F-FA45070A32EDQ47100621-4E3B5172-0EEA-4A2E-BC21-D96C8C000E96Q47621224-47CAE32A-CFCA-443C-8745-9CA97827AFC4Q47727611-1A5F90CC-930F-44FD-A032-F64D14871098Q50043138-B2919AA0-D352-4F53-B221-EE066DDE5256Q52894575-9AED4A28-6225-4EB3-988E-F0BC7ECBA526
P2860
The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
@ast
The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
@en
type
label
The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
@ast
The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
@en
prefLabel
The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
@ast
The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
@en
P2093
P2860
P1433
P1476
The variable phenotype and low-risk nature of RAS-positive thyroid nodules
@en
P2093
Atul A Gawande
Carol B Benson
Daniel T Ruan
Edmund S Cibas
Ellen Marqusee
Erik K Alexander
Francis D Moore
Jeffrey F Krane
Justine A Barletta
Marco Medici
P2860
P2888
P356
10.1186/S12916-015-0419-Z
P407
P577
2015-08-07T00:00:00Z
P5875
P6179
1009131413